StonvexLoading…
StonvexStonvexStonvexCore line items from LCNB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2014 2014-06-30 | Q1 2014 2014-03-31 | Annual 2013 2013-12-31 | Q3 2013 2013-09-30 |
|---|---|---|---|---|
Revenue | $2.64M | $1.14M | $6.45M | $4.56M |
Operating Income | $3.45M | $1.69M | $11.72M | $3.16M |
Net Income | $2.61M | $1.32M | $8.78M | $2.36M |
EPS (Diluted) | $0.28 | $0.14 | $1.10 | $0.83 |
Total Assets | $1.15B | $1.13B | $932.34M | $942.35M |
Total Liabilities | $1.03B | $1.01B | $813.47M | $850.13M |
Cash & Equivalents | $18.88M | $33.42M | $14.69M | $14.69M |
Free Cash Flow OCF − CapEx | $3.67M | $792.00K | $9.58M | $6.20M |
Shares Outstanding | 9.41M | 9.41M | 7.98M | 7.72M |